Presley Gerber's Death Sparks Questions on Addiction Recovery Risks

The recent death of Presley Gerber at the age of 27 has brought renewed attention to the complexities and potential risks associated with addiction recovery, including overdose, withdrawal complications, and the safety of rehabilitation facilities. Gerber, the son of Cindy Crawford and Rande Gerber, died on Sunday at a California rehabilitation center, according to Los Angeles County Medical Examiner’s Office records.

While an official cause of death has not been released, initial reports from audio recordings suggest a 911 call reported cardiac arrest at the facility, with a separate dispatch indicating a potential overdose. An autopsy has been completed, but the results are pending further testing.

Gerber had previously spoken publicly about his struggles with substance use and mental health. His death occurred while he was in a rehabilitation facility, prompting discussions about the inherent risks even within controlled treatment environments.

Understanding Recovery Risks

Nicholas Kardaris, Ph.D., CEO of the New York Center for Living, cautioned against drawing immediate conclusions about Gerber's death based on its location. He noted that individuals in treatment often have complex medical histories, and unforeseen conditions can arise. "Younger people can sometimes die suddenly, and we don’t know whether they had an underlying medical issue," Kardaris stated. He added that medication-related events, particularly for those with underlying heart conditions, are also a possibility.

Kardaris emphasized that entering rehab does not signify an end to addiction struggles. "People are in rehab because they’re struggling with addiction. It doesn’t mean they’re cured of their addiction," he explained. Treatment facilities strive to create a safe environment, but they cannot eliminate all risks associated with addiction, withdrawal, or medical complications.

Withdrawal Dangers

Withdrawal from certain substances can pose significant risks, ranging from severe discomfort to life-threatening situations. Kardaris identified benzodiazepines, such as Valium and Xanax, and alcohol as particularly dangerous to withdraw from without medical supervision, citing the potential for seizures and other fatal complications. While opioid withdrawal is typically not fatal on its own, it can be intensely uncomfortable.

Following detoxification, individuals with opioid use disorder face an increased risk of overdose if they resume previous usage levels, as their tolerance may have decreased. "If someone relapses after rehab, they may use the same amount they were using before treatment — but their tolerance has gone down, and that amount can now be fatal," Kardaris explained.

Experimental Treatments and Oversight

Gerber had previously mentioned undergoing ibogaine treatment in Mexico. Kardaris noted that ibogaine is not FDA-approved in the U.S. and its safety and effectiveness for treating opioid use disorder are still under investigation. He grouped ibogaine with other substances like ketamine and ayahuasca, which have gained attention for potential therapeutic benefits but remain largely unregulated.

While some of these substances are being studied for their psychoactive or psychedelic properties, their use in treatment settings is still considered experimental. Ketamine is FDA-approved as an anesthetic but is used off-label for certain mental health conditions. Ibogaine and ayahuasca lack FDA approval in the U.S., and regulatory oversight varies significantly.

Vetting Treatment Programs

Kardaris advised families seeking treatment for a loved one to thoroughly investigate rehabilitation centers. This includes verifying that the facility is licensed and that qualified medical professionals are involved in patient care. "Families should make sure licensed professionals are working there and that the program has a strong reputation," he said. He stressed the importance of finding reputable programs with qualified staff, acknowledging that unqualified individuals can operate in the field.